CD68 and neoplasm: By using multiplexed immunofluorescence for the simultaneous visualization and quantification of CD68 + macrophages, CD8 + T cells, FOXP3 + regulatory T cells, PD‐L1/PD‐1 protein expression, and tumor cells from 250 patients, Daniel Jiménez‐Sánchez and colleagues trained a multilevel DL model to accurately assess the risk of recurrence in EC [22].